TMDX
TransMedics Group, Inc.
Medical Devices · Healthcare · United States
89.64
close · 2026-08-13
value
15
cheaper than peers15
quality
86
stronger fundamentals86
ranked against
Medical Devices
value
quality
55 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 5.99× | 31 |
| price to sales | 4.59× | 31 |
| forward P/E | 38.88× | 21 |
| EV to EBITDA | 28.57× | 17 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 36.3% | 97 |
| revenue growth | 20.7% | 79 |
| operating margin | 12.5% | 74 |
| debt to equity | 167.5% | 24 |
4 of 4 measures available
Facts
| market cap | $3B |
| free cash flow | $44.5M |
| employees | 898 |
| first trade | 2019-05-02 |
| next earnings | 2026-08-04 |
| fundamentals updated | 2026-08-10 |